Member Info for MOG14

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Did you read today's new on a drug called obe-cel developed in the UK by Autolus.

Apparently 77% of patients entering remission after treatment.

NICE now approved for treatment on patents with B-cell acute lymphoblastic leukaemia.

Https://ir.tizianalifesciences.com/static-files/166adf78-dea2-44a2-b417-85f64d17c4d4

Use FILTERS

for those of us that have, its even more annoying going thru the messages of those who answer the morons

We want a constructive board

Didn't you say you sold all your shares at the beginning of the year?

By my reckoning in the hands of 3 individuals

Happy to sit and hold until takeover

GLA

SEC announce today Jorey Chernet controls 7.3 million or 6.1% of shares of Tiziana

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

Big news

Simples

Now back to the football

At my old trading records, 26/8/20 i sold at 15p per share (that's before the 400/1 consolidation) in today's money that's £60 per share

that was the last time i sold HEMO, since then i weathered the storms, averaged down and increased my holding

At the time we only had COVID hype to propel the share price, now we have meaningful progress in the science

People are taking notice of the achievements to date and most importantly how the success in the laboratory will bring about real health benefits

its been 5 years, but i plan to hold all my HEMO shares until we have exceeded £60

GLA

Shareoursuccess, looking at your history it looks like you sold out of this company some time ago

That being the case why are you still posting here?

Just move on

Or take advantage of a great buy in price today and look to the future of the science succeeding with the good it will do to health.

GLA investors

Yes great news

having powered to $2 in recent months, there was a bit of a lull

On the back on this news i can see this heading to $3 before end of Sep

don't forget the recent purchases by management recently

MM will play games with the price in order to release more shares, don't fall for the trap

GLA

So good to see

1 for 20

Acut, Accustem was the spin off, round about the time the company moved to nasdaq

Check out the history of the man in charge

He has a history of nurturing small companies to success before selling on to global pharma

Indeed some went for $billions

GLA

Lucid Capital initiated coverage with a $8 target (12 months)

Not so fanciful in my opinion, if you consider how effective this could be in treating the many million's of people who do/will suffer with Alzheimer's.

What price then could a major charge for a drug that targets this horrible disease

My hope is that a major buys out our company in the very near future in order that they can progress this wonderful treatment much faster for the benefit of all.

Good luck all

Looking like we clearly $2 today

That's a rise of 100% sine April

Looking like we clearly $2 to